Lumina Datamatics Earns Great Place to Work® Certification, Acknowledging its Commitment to Employee Satisfaction and Well-being
January 18, 2024 16:13 ET
|
Lumina Datamatics, Inc.
MUMBAI, India, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Lumina Datamatics, a leading partner in providing Content Services, Retail Support Services, and Technology Solutions to global companies in the...
National Bank Holdings Corporation Announces Quarterly Dividend
January 18, 2024 16:10 ET
|
National Bank Holdings Corporation
DENVER, Jan. 18, 2024 (GLOBE NEWSWIRE) -- National Bank Holdings Corporation (NYSE: NBHC) announced today that its Board of Directors approved a cash dividend to shareholders. The quarterly cash...
Snap One Launches Control4 Connect & Control4 Assist to Elevate the Customer Experience and Create New Recurring Revenue Opportunities for Partners
January 18, 2024 16:10 ET
|
Snap One, LLC
CHARLOTTE, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- In a significant move to evolve the core business model of the Custom Integration industry, Snap One (Nasdaq: SNPO) today announced the launch of...
South Plains Financial, Inc. Declares Quarterly Cash Dividend
January 18, 2024 16:10 ET
|
South Plains Financial, Inc.
LUBBOCK, Texas, Jan. 18, 2024 (GLOBE NEWSWIRE) -- South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains”), the parent company of City Bank, today announced that its Board of Directors has...
Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium
January 18, 2024 16:05 ET
|
Coherus BioSciences, Inc.
– Data demonstrate early activity with casdozokitug/atezolizumab/bevacizumab; 38% objective response rate including three complete responses – – Data support casdozo as a promising novel...
Americold Realty Trust, Inc. Announces 2023 Tax Treatment of Distributions
January 18, 2024 16:05 ET
|
Americold Realty Trust
ATLANTA, GA., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Americold Realty Trust, Inc. (NYSE: COLD) (the “Company”), a global leader in temperature-controlled logistics, real estate, and value-added services...
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
January 18, 2024 16:05 ET
|
Ikena Oncology, Inc.
IK-930 optimized formulation now in the clinic; on track to deliver additional monotherapy data in 2H 2024 IK-595 first cohort treated and cleared safety evaluation window Focused execution on core...
Leslie’s, Inc. to Report First Quarter Fiscal 2024 Financial Results on February 1, 2024
January 18, 2024 16:05 ET
|
Leslie’s Inc.
PHOENIX, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Leslie’s, Inc. (NASDAQ: LESL), the largest and most trusted direct-to-consumer brand in the U.S. pool and spa care industry, today announced that its...
AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference
January 18, 2024 16:05 ET
|
AEON Biopharma
– Open label extension (OLE) Phase 2 data show peak efficacy for all ABP-450 doses and cycles in treating cervical dystonia (CD) occurred early, within 4 weeks; durability of effect was demonstrated...
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
January 18, 2024 16:05 ET
|
NextCure
BELTSVILLE, Md., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class...
- July 25, 2024 15:56 ET "Best in Grass" Competition in nuEra Dispensaries: Chicago, Urbana, and East Peoria
- July 25, 2024 15:53 ET EvenMix Launches Heavy Duty Drive for Efficient Mixing